LLY ▲ +0.3% - Eli Lilly and Company $LLY - Lilly's Foundayo (orforglipron) 17.2 mg showed greater weight loss and A1C reduction than oral semaglutide 25 mg among adults with type 2 diabetes in a new indirect treatment comparison 29-SEP-2026 03:00 AM ET